Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma

BACKGROUND: Chemotherapy resistance is a leading cause of treatment failure in cases of cervical adenocarcinoma (ADC), and no effective treatment approach has yet been found. We previously identified the differentially expressed kynureninase (KYNU) mRNA in cervical adenocarcinoma cells (HeLa) and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun-wen, Wang, Ya-nan, Zhong, Mei-ling, Liang, Mei-rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518096/
https://www.ncbi.nlm.nih.gov/pubmed/37742026
http://dx.doi.org/10.1186/s13008-023-00098-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518096/
https://www.ncbi.nlm.nih.gov/pubmed/37742026
http://dx.doi.org/10.1186/s13008-023-00098-3

Ejemplares similares